Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA ...
The Danish drug giant Novo Nordisk, known for its antidiabetes and weight loss drugs such as semaglutide (Ozempic or Wegovy), has been censured by the UK’s Prescription Medicines Code of Practice ...
The Prime Minister, Shri Narendra Modi inaugurated the Whitefield (Kadugodi) to Krishnarajapura Metro Line of Bangalore Metro today. He also took a ride in the newly inaugurated metro. The Prime ...
Noel Smith posted 21 points, seven rebounds and five steals to lead the Whitefield Academy girls basketball team to a 35-30 victory over Knott County Central on Wednesday in the first round of the ...
Whitefield Academy and Holy Cross will represent Louisville in this week’s All “A” Classic state basketball tournaments in Owensboro. The girls tournament will tip off Wednesday, and the ...
Novo Nordisk has announced topline results from the phase 3b trial STEP UP, which investigated the effects of two doses of Wegovy (semaglutide) in over 1,400 patients over the course of 72 weeks. Both ...
On Tuesday, BofA Securities expressed continued confidence in Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), maintaining a Buy rating and a price target of DKK1,075.00. The endorsement comes amidst ...
Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results